| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0079 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |